Latest Breaking News On - Vesteck inc - Page 1 : comparemela.com

Sean Lyden MD, Professor and Chairman Vascular Surgery Cleveland Clinic on the mainstage at ISET 2024

/PRNewswire/ VESTECK, Inc. is excited to announce that the "SUTURE-TIGHT"tm catheter technology was presented at the iconic ISET meeting in Miami FL on.

United statesCleveland clinicJoe raffertySource vesteck incPrnewswire vesteck incVesteck incSean lydenChairman vascular surgery cleveland clinicHealth care amp hospitalsMedical pharmaceuticals

VESTECK, invited to present at the 16th Annual Greenberg Stent Summit, Boston, MA

VESTECK, invited to present at the 16th Annual Greenberg Stent Summit, Boston, MA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRamon varcoeJoe raffertyAndrew holdenTed wulfmanVesteck incSource vesteck incChief technology officerStent summitMass generalBoston stent

VESTECK, invited to present at the 16th Annual Greenberg Stent Summit, Boston, MA

/PRNewswire/ The VESTECK, Inc. Chief Technology Officer, invited to present the "SUTURE-TIGHT"™ technology at the 16th Annual Greenberg Stent Summit,.

United statesAndrew holdenTed wulfmanRamon varcoeJoe raffertySource vesteck incVesteck incChief technology officerAnnual greenberg stent summitMass generalGreenberg stent summitStent summitBoston stentProfessors ramon varcoe

VESTECK, Inc it is always someone s mom or dad, brother or sister

VESTECK, Inc it is always someone s mom or dad, brother or sister
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesDainis krievinsJoe raffertySource vesteck incUniversity of rigaVesteck incVascular surgeonsInterventional radiologistsVascular surgeonPauls stradins clinical university hospital

Resorbable Scaffold Beats Angioplasty in Below-Knee CLTI

A drug-eluting resorbable scaffold was superior to angioplasty in treating infrapopliteal artery disease and chronic limb-threating ischemia and was noninferior for safety in the LIFE-BTK trial.

United statesNew south walesDuke university medical centerNorth carolinaSan franciscoJennifer rymerDavid kandzariRamon varcoeProvisio medical incPeidmont heart institute in atlantaBoston scientific corporationVesteck incAbbott vascularTranscatheter cardiovascular therapeuticsWales hospitalSuperior efficacy